Financing Small and Medium sized Companies on Top of Europe
The lack of financing dramatically lowers the number of spin-outs from Universities and research institutions which passes the initial phase, where they are financed by public pre-seed financing.
Therefore Bioforum Oulu, Finland, is taking the lead in creating a “Top of Europe” financing network to assist closing the financial gap, which is a barrier for the exploitation of academic research in SME´s throughout the region. The Top of Europe financing network will be the theme for a workshop to be held 9th of June in Göteborg, where experts within financing of life sciences and biotech will discuss how to proceed in order to create a successful collaboration.
Program Director Tuula Palmén, Bioforum Oulu, says “We hope to promote the establishment of the Top of Europe financing network through dialogue with key stakeholders like private investors, SME´s, national and regional innovation and research agencies plus decision- and opinion makers. In order to strengthen competitiveness of the Baltic Sea Region we need to focus on the development of research based SME´s – otherwise we will loose ground to low costs countries”.
The workshop in Göteborg is part of an EU co-funded project (FP 7) “Bridge-BSR” with 7 partners in addition to Bioforum Oulu: BioCan Valley, Estonian Biotech Association, IPPT-PAN, Latvian Association of Biotechnology, Medicon Valley Alliance, ScanBalt and Steinbeis Team North East. Bridge-BSR aims to bridge academic research and SME´s within life sciences and biotechnology in te Baltic Sea Region – ScanBalt BioRegion.
For further information please contact Tuula Palmén at tuula.palmen@bioforumoulu.org, Tel: +358 50 4617290, www.businessoulu.com
About Bioforum Oulu: Bioforum Oulu gathers together biotech companies, universities and R&D organisations in the Oulu region, Finland, and stimulates their co-operation. Bioforum Oulu works closely with other players in the region and also carries out spearhead projects named in the Oulu Growth Agreement. The intent is to develop new products and services that enhance people's health and well-being and to create new business in the field.
About ScanBalt BioRegion: ScanBalt BioRegion is composed of public and private Life Science and biotechnology actors in the Nordic countries, Balticum, Poland, Northern part of Germany and North western Russia. The ScanBalt BioRegion has 11 countries and 85 million people, more than 60 universities and 2149 life science/biotech companies including 671 research based biotech SME's.
Media Contact
More Information:
http://www.scanbalt.orgAll latest news from the category: Business and Finance
This area provides up-to-date and interesting developments from the world of business, economics and finance.
A wealth of information is available on topics ranging from stock markets, consumer climate, labor market policies, bond markets, foreign trade and interest rate trends to stock exchange news and economic forecasts.
Newest articles
Superradiant atoms could push the boundaries of how precisely time can be measured
Superradiant atoms can help us measure time more precisely than ever. In a new study, researchers from the University of Copenhagen present a new method for measuring the time interval,…
Ion thermoelectric conversion devices for near room temperature
The electrode sheet of the thermoelectric device consists of ionic hydrogel, which is sandwiched between the electrodes to form, and the Prussian blue on the electrode undergoes a redox reaction…
Zap Energy achieves 37-million-degree temperatures in a compact device
New publication reports record electron temperatures for a small-scale, sheared-flow-stabilized Z-pinch fusion device. In the nine decades since humans first produced fusion reactions, only a few fusion technologies have demonstrated…
